Advanced Oncotherapy (AVO) has raised £2.7m in a new share issue aimed at obtaining regulatory approval for its first LIGHT system. The company said the…
Advanced Oncotherapy raises £2.7m in new share issue
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
 has raised £2.7m in a new share issue to help the AIM-listed company obtain regulatory approval for its first LIGHT system.){kind=link}